Home
Vista Pharmaceuticals Ltd Share Price History
Vista Pharmaceuticals Ltd
BSE : 09 May, 2025
10.04-0.4 (-3.5%)
Prev Close
10.4
Open Price
10.7
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1691
Today's High / Low
10.7 / 9.9
52 WK High / Low
16.6 / 9.1
Market Price of Vista Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Vista Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 24 |
| Sales YoY Gr. | - |
| Adj EPS | 0.47 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 6.25 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 8.91 |
| Op. Profit Mgn % | 12.9 |
| Net Profit Mgn % | 5.17 |
| Debt to Equity % | 0.69 |
Latest Shareholding
Promoters Holdings Over Time
About Vista Pharmaceuticals Ltd
- Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991.
- The Company is engaged in the formulation of pharmaceutical products.
- It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
- This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
- Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.
Popular Search
FAQs for Vista Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Vista Pharmaceuticals Ltd's share price history?
Key events that impact Vista Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Vista Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Vista Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Vista Pharmaceuticals Ltd?
Dividends can influence Vista Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Vista Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Vista Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Vista Pharmaceuticals Ltd’s share price history?
To understand Vista Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
